With regard to the latter, several reports have described low IGF-1 blood levels as well as decreased placental expression of IGF-1 in women with preeclampsia, and this has been hypothesized to play a role in the future risk of breast and other cancers [20–25]. This evidence concerns the gene IGF1 and preeclampsia.